These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Fine specificity of ligand-binding domain 1 in the polymeric Ig receptor: importance of the CDR2-containing region for IgM interaction. Røe M, Norderhaug IN, Brandtzaeg P, Johansen FE. J Immunol; 1999 May 15; 162(10):6046-52. PubMed ID: 10229845 [Abstract] [Full Text] [Related]
7. The three complementarity-determining region-like loops in the second extracellular domain of human Fc alpha/mu receptor contribute to its binding of IgA and IgM. Yang X, Zhao Q, Zhu L, Zhang W. Immunobiology; 2013 May 15; 218(5):798-809. PubMed ID: 23182711 [Abstract] [Full Text] [Related]
9. Characterization of a monoclonal antibody, D73H, that maps to a highly conserved region on fibrinogen Bbeta chain. Rybarczyk BJ, Pereira M, Simpson-Haidaris PJ. Thromb Haemost; 2000 Jul 15; 84(1):43-8. PubMed ID: 10928468 [Abstract] [Full Text] [Related]
11. NMR analysis of the interaction between protein L and Ig light chains. Enokizono J, Wikström M, Sjöbring U, Björck L, Forsén S, Arata Y, Kato K, Shimada I. J Mol Biol; 1997 Jul 04; 270(1):8-13. PubMed ID: 9231896 [Abstract] [Full Text] [Related]
12. Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold. Jespers L, Schon O, James LC, Veprintsev D, Winter G. J Mol Biol; 2004 Apr 02; 337(4):893-903. PubMed ID: 15033359 [Abstract] [Full Text] [Related]
13. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains. van den Beucken T, van Neer N, Sablon E, Desmet J, Celis L, Hoogenboom HR, Hufton SE. J Mol Biol; 2001 Jul 13; 310(3):591-601. PubMed ID: 11439026 [Abstract] [Full Text] [Related]
14. Secretory component delays the conversion of secretory IgA into antigen-binding competent F(ab')2: a possible implication for mucosal defense. Crottet P, Corthésy B. J Immunol; 1998 Nov 15; 161(10):5445-53. PubMed ID: 9820520 [Abstract] [Full Text] [Related]
15. Mutational analysis of polymeric immunoglobulin receptor/ligand interactions. Evidence for the involvement of multiple complementarity determining region (CDR)-like loops in receptor domain I. Coyne RS, Siebrecht M, Peitsch MC, Casanova JE. J Biol Chem; 1994 Dec 16; 269(50):31620-5. PubMed ID: 7989333 [Abstract] [Full Text] [Related]
16. In vivo experiments involving secretory component in the rat hepatic transfer of polymeric IgA from blood into bile. Lemaître-Coelho I, Altamirano GA, Barranco-Acosta C, Meykens R, Vaerman JP. Immunology; 1981 Jun 16; 43(2):261-70. PubMed ID: 7251055 [Abstract] [Full Text] [Related]
17. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. Renegar KB, Jackson GD, Mestecky J. J Immunol; 1998 Feb 01; 160(3):1219-23. PubMed ID: 9570537 [Abstract] [Full Text] [Related]
18. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47. Nakaishi A, Hirose M, Yoshimura M, Oneyama C, Saito K, Kuki N, Matsuda M, Honma N, Ohnishi H, Matozaki T, Okada M, Nakagawa A. J Mol Biol; 2008 Jan 18; 375(3):650-60. PubMed ID: 18045614 [Abstract] [Full Text] [Related]
19. Expression and purification of biologically active domain I of the human polymeric immunoglobulin receptor. Bakos MA, Widen SG, Goldblum RM. Mol Immunol; 1994 Feb 18; 31(2):165-8. PubMed ID: 8309479 [Abstract] [Full Text] [Related]
20. Conservation of a polyanion binding site in mammalian and avian CD4. Parish CR, Warren HS. Immunology; 1991 Oct 18; 74(2):191-6. PubMed ID: 1748468 [Abstract] [Full Text] [Related] Page: [Next] [New Search]